OncoSec Medical Inc (ONCSQ)

[jbem777]

It's an open label study, so expect interim results mid year. At the last conference Punit stated that since it was a multi center study, using the current standard of care, that enrollment would occur quickly and full results are expected at the end of 2015 or early 2016. If interim results are good, expect a buy out. Merck, BMY, or AZN can not let ONCS usurp the standard of care and I would expect a bidding war, as the combination could make pd1 alone, obsolete.